Refined Energy Corp (RFMCF)

[Market_Stalker]

I’d just like to point out that after Chemesis released its PR on Jay and SB, the number of posts to this board effing skyrocketed compared to the average.

Chemesis is forward thinking. Branding will likely be the difference between winners and losers. Chemesis realizes that. J and SB, California Sap, Julian Marley... I’m probably missing something.

$$$CADMF$$$

[Market_Stalker]

Snoochie Boochies.

[Talc Moan]

Indeed and Agree!!

CAMDF

[Fat Thor]

Those were the days...

Pretty wild news here. More interesting is the chart and volume. Gaps everywhere. Minimal float it would appear. Will be watching this closely.

[Talc Moan]

15 bucks, little man, put that sh*t in my hand.
If that money doesn't show then you owe me owe me owe.

CAMDF

Man that was my time! lol

These guys ruled!

[Fat Thor]

https://www.otcmarkets.com/stock/CADMF/news/Jay-and-Silent-Bob-Enter-the-Cannabis-Products-Market----CFN-Media?id=212388

[Market_Stalker]

November 30, 2018 08:00 ET | Source: Chemesis International Inc.
VANCOUVER, British Columbia, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is pleased to announce that it will be completing a private placement financing of convertible debentures (“Convertible Debentures”) for gross aggregate proceeds of CDN$2,000,000 (the “Private Placement”). Each Convertible Debenture will bear interest at a rate of 8.0% per annum and have a two-year maturity date (“Maturity Date”). In addition, each Convertible Debenture will be unsecured and will be convertible, at the option of the holder, into common shares of the Company (“Common Shares”) at a price of $1.25 per Common Share.

The Company will have the right to repay and cancel the Convertible Debentures at any time prior to the Maturity Date at a price equal to 105% of the principal amount of the Convertible Debentures then outstanding plus accrued and unpaid interest thereon. In addition, the Company will have the right to compel the conversion of the Convertible Debentures in the event that the daily volume weighted average trading price of the Common Shares exceeds $2.50 per Common Share for 10 consecutive trading days.

Each placee will also be granted one Common Share purchase warrant (“Warrants”) for each Common Share underlying the Convertible Debentures. Each Warrant will be exercisable into one Common Share at an exercise price of $1.50 for a period of 24 months.

The Company notes that all of the placees are insiders of the Company.

The Company anticipates that the Private Placement will complete on or before December 4th, 2018.

About Chemesis International Inc.

Chemesis International Inc. is a vertically integrated global leader in the cannabis industry, currently operating within California, Puerto Rico, and finalizing acquisition in Colombia.

Chemesis is developing a strong foothold in key markets, from cultivation, to manufacturing, distribution, and retail. Chemesis has facilities in both Puerto Rico and California, allowing for cost effective production and distribution of its products. In addition, Chemesis leverages exclusive brands and partnerships and uses the highest quality extraction methods, to provide consumers with quality cannabis products.

Chemesis will add shareholder value by exploring opportunities in emerging markets while consistently delivering quality product to its consumers from seed to sale.

ON BEHALF OF THE BOARD OF DIRECTORS
Edgar Montero
CEO and Director

INVESTOR RELATIONS:
[e-mail]
www.chemesis.com
1 [phone]

Forward-Looking Information: This news release contains "forward-looking information" within the meaning of applicable securities laws relating to statements regarding the Company's business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company's products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend, to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release

[Market_Stalker]

Oops, I did not mean to post that GDET article here. My bad yo

[Market_Stalker]

Emerging Growth Cryptocurrency ATM Company Among Those Receiving Institutional Capital https://finance.yahoo.com/news/emerging-growth-cryptocurrency-atm-company-110000403.html

[Market_Stalker]

Chemesis International Inc. Signs Exclusive Licensing Deal https://finance.yahoo.com/news/chemesis-international-inc-signs-exclusive-081500666.html

[Market_Stalker]

The s/p just gapped up $0.278 on 3,857 in volume. Lol! I love this stock.

[Jdoggg]

NEWS!! https://www.ftmig.com/cannabis/chemesis-international-inc-signs-binding-agreement-to-acquire-100-of-colombia-based-cannabis-company-la-finca-interacviva-arachna-med/

[Market_Stalker]

Chemesis International Inc. Announces Intention to Enter into Canadian Medical & Recreational Cannabis Market
BY GlobeNewswire
— 3:15 AM ET 10/16/2018
VANCOUVER, British Columbia, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Chemesis International Inc. ( CADMF
Loading...
Loading...
) (OTC:CADMF) (the “Company” or “Chemesis”), announces its intention to enter the recreational and medical cannabis market in Canada. The Company is reviewing possible joint ventures, agreements or acquisitions in distribution, manufacturing, and product development spaces. Chemesis ( CADMF
Loading...
Loading...
) intends on leveraging its assets, brands, and management expertise to gain market share in Canada. Chemesis ( CADMF
Loading...
Loading...
) is presently performing due diligence on fully licensed and operational cannabis companies in Canada.

Canada has significant opportunity in both recreational and medical markets, with the Canadian cannabis market expected to generate up to $7.17 billion CDN in 20191. The Company sees major opportunities in Canada from high-quality manufacturing to brands that have developed a strong presence in the market. Chemesis ( CADMF
Loading...
Loading...
) aims to introduce Canadian consumers its portfolio of brands which includes California Sap, the Company’s flagship brand. California Sap has been recognized in California since 2012, with 25 gold rankings for best CO², best topical, best product, best concentrate, best cartridge, highest terpene and more.

1 Deloitte – 2018 Cannabis Report

“The Company is looking at multiple opportunities in Canada that will allow us to enter the market and gain a strong presence with minimal regulatory hurdles,” said CEO, Edgar Montero. “Chemesis is only evaluating businesses that have met regulatory and compliance standards. This allows the Company to enter into the market with our assets, and expertise without unnecessary delay. The introduction of California Sap and our other brands will allow Canadians the ability to purchase premium brands, that are extremely accomplished in California. As we continue to execute our business plan, Chemesis ( CADMF
Loading...
Loading...
) will look for acquisitions and partnerships that bring growth and shareholder value.

About Chemesis International Inc. ( CADMF
Loading...
Loading...
)

Chemesis International Inc. ( CADMF
Loading...
Loading...
) is a vertically integrated global leader in the cannabis industry, currently operating within Puerto Rico, and California.

Chemesis ( CADMF
Loading...
Loading...
) is developing a strong foothold in key markets, from cultivation, to manufacturing, distribution, and retail. Chemesis ( CADMF
Loading...
Loading...
) has facilities in both Puerto Rico and California, allowing for cost effective production and distribution of its products. In addition, Chemesis ( CADMF
Loading...
Loading...
) leverages exclusive brands and partnerships and uses the highest quality extraction methods, to provide consumers with quality cannabis products.

Chemesis ( CADMF
Loading...
Loading...
) will add shareholder value by exploring opportunities in emerging markets while consistently delivering quality product to its consumers from seed to sale.

ON BEHALF OF THE BOARD OF DIRECTORS
Edgar Montero
CEO and Director

INVESTOR RELATIONS:
[e-mail]
www.chemesis.com
1 [phone]

Forward-Looking Information: This news release contains "forward-looking information" within the meaning of applicable securities laws relating to statements regarding the Company's business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company's products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend, to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release

Image: Chemesis ( CADMF
Loading...
Loading...
) - Logo - Vertical - Color - 10,000W.png

Source: Chemesis International Inc. ( CADMF
Loading...
Loading...
)
MORE CADMF NEWS
Chemesis International Inc. & Rapid Dose Therapeutics Sign a Definitive Agreement for QuickStrip™ Oral Thin Strips
GlobeNewswire - 4:00 AM ET 10/12/2018
Chemesis International Inc. Signs Agreement for Packaging, Fulfillment & Distribution for Julian Marley JuJu Royal Brand
GlobeNewswire - 3:15 AM ET 10/11/2018
Chemesis International Inc. Enters Into the Cannabis Edibles Market
GlobeNewswire - 3:15 AM ET 10/09/2018

[Market_Stalker]

I’m scratching my head trying to figure out why people aren’t more interested in this company. I guess it’s because it’s not all hyped up like so many others here...?

[SmokeABull]

With NO financial reports, it’s really tough to gamble on this one. Could be a winner or could be the next pump and dump weed stock

[Market_Stalker]

NEWS!!!

https://globenewswire.com/news-release/2018/10/09/1618255/0/en/Chemesis-International-Inc-Enters-Into-the-Cannabis-Edibles-Market.html

[Market_Stalker]

This company has enormous potential and is consistently increasing in value. It boggles my mind that this company is still flying under the radar. Go $CADMF!!!

[Market_Stalker]

More publicity: https://www.prnewswire.com/news-releases/global-cannabis-value-expected-to-keep-growing-as-north-america-dominates-the-market-882789930.html

[Market_Stalker]

A great write up today published by Nasdaq

https://www.nasdaq.com/press-release/chemesis-rolling-up-high-value-cannabis-assets-in-united-states--cfn-media-20181005-00390

[Market_Stalker]

NEWS!!! The global cannabis market has a projected CAGR of 24% until 2021. The CBD segment is predicted to grow at a CAGR of more that 39%!!!

The takeaway: people getting hung up on the daily ups and downs need more hobbies because the industry will be growing steadily for a couple more years.


https://www.prnewswire.com/news-releases/global-cannabis-market-grows-with-uk-legalization-of-cannabis-derived-medical-products-838753396.html

[SmokeABull]

Who’s Edgar Montero and what’s his CEO experience like? Does he know much about growing and selling cannabis? Who are his advisors?

These are all good questions to know before giving him your money.

[Market_Stalker]

Today was great, and this one has so much further to go.

[Northwest 12]

Still low volume days, slowly picking up steam.
Imagine what will happen, when the market really discovers the potential here.

[Market_Stalker]

https://www.prnewswire.com/news-releases/u-s-medical-cannabis-market-is-set-to-grow-as-edible-product-popularity-increases-899304057.html

[Market_Stalker]

...like it’s ready to be gobbled up

[kutchmaster]

Looks tasty ??

[Market_Stalker]

Posted today on stockhouse by Dart321...

"The news yesterday could turn out to be substantial, we will have to wait to see what the continuation news will be like. Everyone notice Tilray. Their share price is over $100 U.S. fantastic. It gives us some Idea how pot stocks are being valued. I think this company has more assets than Tilray but there is one huge difference they have announced sales and have growing cash flow month over month. In my opinion that's what will pop this stock, announcements of sales."

The news Dart321 is referring to is discussed in the link I posted below.

[Market_Stalker]

Latest News. This sleeper is just waking up.

https://www.nasdaq.com/press-release/chemesis-international-inc-announces-global-expansion-through-wholly-owned-subsidiary-chemesis-20180911-00071